Background: The female breast loses superior fullness and becomes more ptotic over time. Women often present to their plastic surgeon requesting reversal of this evolution. While liposuction alone has been proven to lift the breast, no solution combining augmentation and liposuction has been reported. Objectives: Herein, we introduce a technique called liposuction-augmentation mammaplasty (LAM) that can achieve "scarless" lifting or simply volume equalization prior to inserting same-sized implants. We then compare its safety and efficacy to two gold-standard techniques with similar aims, mastopexy-augmentation mammaplasty (MAM) and reduction-augmentation mammaplasty (RAM). Methods: A retrospective 3-year chart review was conducted on 359 patients (652 breasts) undergoing LAM (n = 125), MAM (n = 188), and RAM (n = 46). Patient demographics, operative details, and revisions were documented. Degree of lift was measured on pre-and postoperative photographs using sternal notch-to-nipple distances (SN-N). Statistical differences were assessed between the groups. Results: The LAM group's mean age and OR time (37 years, 46 minutes) were significantly lower than those of MAM (43 years, 90 minutes) and RAM (42 years, 106 minutes). Mean BMIs and revision rates were uniform between the LAM and MAM groups (24, 2.5%), but significantly higher for RAM (28, 4.6%). Aspirate volumes and resection weights averaged 151 cc and 307 g (left breast) and 173 cc and 298 g (right breast). Minimum follow up was 12 months. The LAM group's mean SN-N reduction (~6%) was statistically significant, albeit much lower than MAM (~16%) and RAM (~22%). Conclusions: LAM is a safe, facile, reliable solution for the ptotic, fatty breast. Patients can direct their volumetric outcome and enjoy lower costs and shorter downtime.
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As the female breast ages, a combination of gravity, weight fluctuation, pregnancy, and breastfeeding cause elongation of Cooper's ligaments and stretching of the skin brassiere, 1,2 which may manifest as striae and areola enlargement. The breast frequently becomes deflated with loss of superior fullness, softer from increased fat deposition and depleted glandular tissue, and ptotic with downturned nipples. Two well-established surgeries altering this course include mastopexy-augmentation mammaplasty (MAM) [3] [4] [5] [6] [7] and reduction-augmentation mammaplasty (RAM), [8] [9] [10] both of which require anterior scars.
One technique that has gained traction is breast liposuction, [11] [12] [13] [14] [15] [16] [17] [18] which we combine with immediate submuscular augmentation to achieve "scarless" enhancement with nipple-areola complex (NAC) elevation. Besides lifting the breast, this procedure also serves to equalize breast volumes ahead of placing same size implants. We refer to this procedure as liposuction-augmentation mammaplasty (LAM). To our knowledge, no technique whose goal is to achieve fuller, firmer, lifted breasts has been described combining augmentation with liposuction as the sole lifting modality. This study's aims are to: identify LAM candidates; describe the surgical technique; emphasize postoperative instructions; and compare results and complications of a LAM series to the two aforementioned lift-augmentation procedures, MAM and RAM.
METHODS

Terminology
The latter three terms-LAM, MAM, and RAM-appear throughout the manuscript and warrant clarification. In each of these procedures, breast parenchyma and/or skin is removed, and implants are inserted. Moreover, each procedure may be performed in a single operative setting. Distinctions are as follows:
In LAM, fat is removed via suction-assisted lipectomy. For this study, 25 cc was deemed the minimum aspirate to qualify. In MAM, redundant skin envelope is eliminated with minimal-to-no parenchymal reduction, translating the NAC superiorly. RAM similarly relocates the NAC; however, more parenchymal volume is removed through suction, excision, or both. For simplification, we henceforth assume that all RAMs employed excision alone. One author defines breast reduction as at least 300 g, 10 while another surgeon includes those under 200 g. 19 In this article, the delineation between MAM and RAM was arbitrarily set at 200 g of tissue removed per breast (ie, RAM ≥ 200 g and MAM < 200 g).
Patients and Study Design
In May 2016, a retrospective chart review was performed on 359 consecutive females who underwent single-staged LAM, MAM, or RAM by the senior surgeons (P.R. and S.W.H.) between March 31, 2013 and March 31, 2016. All patients provided written informed consent and received preoperative clinical breast examinations and mammograms. Exclusion criteria consisted of biologic males, patients lost to follow up prior to 12 months, LAMs using an instrument other than power-assisted liposuction (PAL), LAMs with concomitant free nipple grafting, and RAMs incorporating liposuction in addition to tissue resection. LAMs involving implant exchange to a new size were not excluded, nor were those in which volumetric equalization was the only goal. This study was conducted in accordance with Declaration of Helsinki guidelines.
Patient demographics, operative details, and implant data were collected. Operative times were recorded only for bilateral cases without concomitant procedures. Capsular contracture was defined as Baker grade II or higher. Adverse outcomes necessitating revisions were documented, whereas easily manageable complications such as poor scarring, excess skin, and suture rejection were omitted. Standard breast photographs 20 were taken of each patient preoperatively and at least 12 months postoperatively. Sternal notch-to-nipple (SN-N) distances were measured using Adobe Photoshop CS6 (Adobe Systems, Inc., San Jose, CA). To standardize SN-N distances, we divided them by a constant-the interaxillary length ( Figure 1 ). Pre-to postoperative per cent changes were calculated.
Statistical analysis was performed with WINKS SDA 7.0 software (TexaSoft, Cedar Hill, TX). Student-NewmanKeuls multiple comparison analysis was utilized to compare mean ages, BMIs, operating times, and per cent SN-N changes of the LAM vs MAM and LAM vs RAM groups. A single sample t test was conducted to assess whether the mean per cent SN-N change was statistically significant for each procedure. Chi-square contingency table analysis was used to compare the percentages of smokers and ethnicities between all 3 groups. Statistical significance was defined as a P-value <0.05. 21 strong skin elasticity, 13 Regnault grade 1 0-1 ptosis, pseudoptosis, 17 patient-perceived ptosis, and minor volume and/or ptosis discrepancy. As with many cosmetic procedures, patients must have reasonable expectations. Those with keloid or hypertrophic scar tendencies gravitate toward LAM rather than procedures leaving visible periareola and vertical scars. Contraindications include advanced age, hypomastia, severe fibroglandularity, grade 3 ptosis, poor skin elasticity as evidenced by diffuse striae, tuberous breast deformity, and anticipated noncompliance. The latter five conditions, along with extreme volume asymmetry and exceedingly high expectations of breast "perkiness," predispose to better outcomes with MAM and RAM.
Patient Selection
While most patients are easily categorized, some fall into a "gray zone" between the extremes of candidacy and require more guidance during consultation. Relative contraindications to LAM include asymmetric areolae, which are more effectively corrected with MAM or RAM, and a history of multiple breast procedures, rendering liposuction more difficult due to increased fibrosis. Similarly, caution is advised in those with darker pigmentation and no cutaneous scars. In our experience, the most common "problem patient" is one who desires very buoyant breasts, yet refuses visible scars. It is up to the provider's discretion when a combination of favorable factors and caveats coexist.
LAM Surgical Technique
Preoperative Planning
In the initial consultation, we discuss the patient's goals (ie, evening out volume asymmetry, lifting, or both). Because liposuction is not the most effective or common method of lifting the breast, we broach alternatives and the possible need for formal mastopexy if LAM falls short of their anticipated lift. This is particularly relevant in women with minimal breast adipose tissue (eg, young, glandular, low BMI). Estimating breast fat and volume asymmetry is important for predicting success. While palpation, body habitus, mammography, and history of breast size changes with weight swings usually suffice, 2, 12, 16, 17 sometimes fat content can only be ascertained intraoperatively. Preoperative sizing is beneficial when determining how large or small the patient wishes to go.
Markings
The following areas are marked on the upright, seated patient: the inframammary fold (IMF); the medial, lateral, and superior extents of the breast to demarcate the boundaries of liposuction; and the area of breast tissue predominance (Figure 2 ). When the nipple is even with or higher than the contralateral side, the NAC becomes the superior boundary.
Procedure
A 3 cm IMF incision is made for both liposuction and implantation. Tumescent solution is injected using the super wet technique. To prevent prosthetic injury, PAL is performed prior to implant placement bearing the following considerations in mind: (1) suction is concentrated at the lower breast (ie, where most of the tissue is located) while aiming for 2 cm tissue thickness distributed evenly across the future implant; (2) conservative liposuction is performed beneath the NAC, avoiding vascular compromise; and (3) minimal fat is evenly removed from the upper pole, careful to avoid a depression (Figure 2) .
A fat-tumescent interface forms in 10 to 15 minutes, allowing accurate quantification of pure fat volume removed. This volume indicates how much additional aspirate is helpful in order to equalize asymmetric breasts and to determine the final implant size. Simple addition dictates that if the patient chose a 300 cc sizer preoperatively and 100 cc of fat is aspirated intraoperatively, then a 400 cc implant is selected.
Release of the pectoralis major from the rib is performed such that a 1 to 2 cm cuff of muscle remains inferomedially to help buttress the implant. At this point, a sizer may be placed into the pocket per surgeon preference. The implant 
Postoperative Protocol
Immediately postoperatively, patients are placed in a sleeveless compression garment with the breast(s) pushed up, then wrapped in an ACE bandage (3M, St. Paul, MN). The latter is removed the following day, while the former is continued for 2 weeks. Unlike MAM or RAM, LAM patients are transitioned to a highly supportive sports bra to be worn continuously for 6 months along with an inferiorly positioned silicone bra insert for additional superior support.
Unilateral LAM patients are instructed to position the nipple of the altered breast higher than the contralateral side, the idea being that scar tissue will form at the shortest length possible, such that the unbuttressed NAC will rest more evenly with the contralateral side at full maturation. If NAC elevation is not imperative, then the support bra is unnecessary. All patients are instructed to massage their breasts from side to side for five minutes twice daily and to obtain a new baseline mammogram at 6 to 12 months. Tables 2-4 display pre-, intra-, and postoperative data. During this three-year review, the senior surgeons performed LAM, MAM, and RAM on 125, 188, and 46 patients, respectively. Given the predominance of bilateral cases, this amounted to 198, 367, and 87 individual breast procedures, respectively, for a total of 652 breasts. Mean follow up was 17 months (range, 12-36 months), 22 months (range, 12-36 months), and 21 months (range, 12-35 months), respectively.
RESULTS
On average, the LAM group was significantly younger (mean, 37 years; range, 19-67 years) than both the MAM (mean, 43 years; range, 20-76 years) and RAM (mean, 42 years; range, 22-62 years) groups (P < 0.05 each). This age gap can be explained by the fact that younger patients self-select for LAM because they are less ptotic preoperatively and less willing to accept scars. 11, 13, 14, 22 Caucasians comprised the majority at 65.6% (LAM), 82.4% (MAM), and 78.3% (RAM), respectively. While the MAM and RAM groups had similar distributions of ethnicities, LAM had fewer Caucasian women and proportionally more Hispanics (P < 0.005).
BMIs averaged 24 kg/m 2 (range, 18-39 kg/m 2 ), 24 kg/ m 2 (range, 18-36 kg/m 2 ), and 28 kg/m 2 (range, 20-43 kg/ m 2 ), respectively. No significant difference was found between the LAM and MAM groups; however, the RAM group's mean BMI was significantly higher than LAM Figure 2 . Markings denoting areas of breast liposuction (right breast). Note that liposuction is concentrated inferiorly, where breast tissue predominates, compared to more limited liposuction superiorly (ie, enough to stimulate collagen production while preventing an indentation in the final appearance). Video 1. Watch now at https://academic.oup.com/asj/ article-lookup/doi/10.1093/asj/sjx174 (P < 0.001), as heavier women tend to require greater lifting. 12.0%, 5.3%, and 8.7% of LAM, MAM, and RAM patients were smokers, respectively, but agreed to quit during the two weeks preceding surgery. No statistical difference existed between the groups in terms of tobacco use (P = 0.104).
Mean operative times increased from 46 minutes (LAM) to 90 minutes (MAM) to 106 minutes (RAM). By comparison, the senior surgeons' most recent 100 bilateral breast augmentations averaged 30 minutes. LAM was significantly shorter than the latter two procedures (P < 0.001 each). All augmentations were bilateral and all implants inserted via an IMF approach. Mean implant volumes were 487 cc, 453 cc, and 430 cc in the left breast and 491 cc, 454 cc, and 430 cc in the right breast, respectively. Most implants were placed submuscularly-97.0%, 96.2%, and 95.4%, respectively. The rest were implant exchanges in which the original subglandular pocket was preserved. Consistent with surgeon Of note, 143 cases not meeting inclusion criteria (transgender females, LAMs not employing PAL, LAMs with sub-25 cc aspirate volumes, RAMs in which liposuction was performed in conjunction with surgical resection, and surgeries beyond the specified date range) were omitted to isolate the study variables, limit confounding bias, and maximize uniformity within each group.
Revision rates were 2.5% (LAM), 2.5% (MAM), and 4.6% (RAM). These arose from capsular contracture refractory to zafirlukast and requiring capsulectomy; implant malposition requiring capsulotomy/capsulorrhaphy; implant failure requiring removal and replacement; breast or areola asymmetry requiring revision; and insufficient lift requiring conversion to mastopexy. See Table 4 for the breakdown within each group. Incidentally, 3 contractures were asymptomatic and did not demand reoperation because the patients were pleased with the unnatural look.
Our higher revision rate for RAM can be explained by its being one of the most complex breast surgeries. The average age of patients requiring revisions approximated or exceeded each group's respective mean age. Whereas only 1 LAM revision occurred in an overweight patient, half of all MAM patients and nearly all RAM patients requiring revisions fell in the overweight-obese BMI range.
Asian patients fared poorly in the MAM group, with 75% undergoing revision. No further trends were observed with respect to ethnicity and complication rates. Only one LAM patient receiving larger implants than the group's mean underwent reoperation; approximately half of all MAM and RAM revisions occurred in such patients. Thus, if any correlations exist, age appears to be a factor, while implant size and BMI become increasingly influential with complexity of surgery.
Regarding lifting in the LAM, MAM, and RAM groups, mean SN-N reductions were 5.9% (range, −3%-22%), 15 .7% (range, 1%-44%), and 22.3% (range, 6%-34%) in the left breast, and 5.8% (range, −10%-20%), 15 .2% (range, 1%-43%), and 20.9% (range, 8%-39%) in the right breast, respectively. One hundred per cent of MAM and RAM patients achieved positive lifting, whereas all but 14 of the 125 LAM patients (11.2%), or 17 of the 198 LAM breasts (8.6%), experienced positive lifting. While all 3 procedures significantly lifted both breasts (P < 0.001 each), the amount afforded by MAM and RAM was significantly greater than that of LAM (P < 0.001). Ten LAM patients (6.1% of LAM breasts) experienced SN-N lengthening. There was no significant difference in lift between breasts with aspirate volumes <100 cc and >200 cc (P = 0.78).
Two LAM subgroups functioned as built-in controls for further lift analysis: (1) 28 patients with asymmetric suctioning (≥25 cc difference bilaterally); and (2) 52 unilateral LAMs with contralateral implantation alone (Figure 1 ). In the first subgroup, there was equal or greater lifting on the side with more suction in 75.0% of the cases. In the second subgroup, there was significantly greater lifting (P < 0.05) on the LAM side based on a two-sample unequal variance one-tailed t test. On the augmentation-only side, SN-N decreased by a statistically insignificant mean of 0.07%. 
DISCUSSION
Prior to 2012, we routinely placed different size implants to correct volume disparities, but noted that other asymmetries persisted. We then employed standard liposuction to facilitate implantation of equal size prostheses. Interestingly, this not only corrected volume asymmetry, but also evened out NAC heights when the larger side had a lower NAC (Figure 3) . Outcomes improved when patients were advised to wear a supportive bra continuously for 6 months. In 2012, we universally adopted PAL because it better maneuvered through dense tissue, was less prone to overdissection (ie, yielded smoother results), depleted fat more efficiently than traditional suction devices, and did so with less vascular injury 23 -an issue plaguing other breast reduction techniques. 18, [24] [25] [26] [27] We had one overriding fear regarding concomitant liposuction-augmentation of the breast, namely, that blood entering the implant pocket would increase the incidence of capsular contracture. Our results do not substantiate this concern, as contracture rates are no higher than in MAM, RAM, or augmentation alone. 28 In fact, LAM's revision rate (2.5%) is significantly lower than that of RAM and no higher than MAM in our hands, likely due to fewer incisions and scars.
Liposuction's capacity to elevate the breast mound and NAC has been demonstrated, 11, 12, 14, 15, 29, 30 although the precise mechanism remains unclear. As there are no current techniques that tighten or shorten Cooper's ligaments, we posit that collagen strands accumulate above the NAC and assist this ligamentous system in bearing the newly lighter breast, which may additionally lessen the chance of waterfall deformity. 31 Two ancillary processes contribute: the support bra and silicone insert reinforce lifting during the 6 months necessary for scar tissue to reach maximal strength; and the areola contraction 11 that sometimes accompanies volume reduction, which enhances subareola skin show and hence perception of lift ( Figure 3) . Conceptually, we believe that the breast benefits from having minimal fibrofatty tissue and a predominant prosthetic component. Once native soft tissue is suctioned, what remains is firmer, glandular tissue, a more rounded surface, and less mass that may fluctuate over time. It may seem counterintuitive or unethical 32 to execute two procedures with ostensibly opposing actions; however, "suction reduction" and augmentation work synergistically insofar as liposuction can firm up the breast and reduce lower pole fullness, while a high-profile implant replenishes upper pole projection 8 to restore more youthful proportions.
Except in the most fibroglandular of breasts, liposuction is easily accomplished and adds only 8 minutes per breast to the operative time. There appears to be no significant distortion to native architecture that might complicate future mammographic interpretation. 12 Liposuction enables minute volume adjustments, albeit major shape improvement is less feasible. 16 While liposuction cannot lift the breast to the same degree as mastopexy (Figure 4 ) or reduction ( Figure 5 ), overlifting is almost never a concern.
Many patients readily accept less dramatic lifting in order to avoid the irreversible anterior scars associated with MAM and RAM (Figures 4 and 5) , a major reason for the ongoing selection/success of LAM in our practice. If patients are unsatisfied with lifting status post LAM, they still have other options available. Although no LAM patient in our series underwent secondary surgery, several are considering future mastopexy ( Figure 6 ). In patients with a history of poor cutaneous scarring, LAM may be their only option. Other features of LAM that our patients appreciate are its lower price point, less invasive nature, and brief recovery process. 15 As mentioned, LAM permits an artificially enhanced appearance as well as volumetric versatility.
Volumetrics is a novel concept that merits further discussion. While augmentation and MAM have always been synonymous with volume gain, the advent of RAM and now LAM have ushered in two more possibilities-net volume neutrality and net volume reduction. Hence, these two procedures (one with anterior scars and one without) can be tailored to a wide gamut of breast volumes. A conversation about breast volumetrics is held at every consultation in which patients can direct their desired size, as well as decide how much scarring they are willing to tolerate.
Another important notion is the utility of same-sized implants. In the context of LAM, we have noted that this yields more consistent symmetry. Different-sized prostheses introduce unwanted variables such as diameter discrepancy, in addition to unequal bilateral tissue response and rates of atrophy. 33 Akin to LAM, deep parenchymal resection (DPR) 33 corrects small volume differences to facilitate symmetric implant placement. However, it neither elevates the NAC nor has the ability to target soft fat. It is unclear whether large volumes can be resected (no more than 82 g was attempted in the DPR study vs suction volumes up to 700 g in ours). We surmise that DPR may be superior to LAM when it comes to removing extremely fibroglandular tissue and in cases where the larger breast is higher preoperatively. In dual plane breast augmentation (DPBA), no tissue is removed to equalize breast volumes; the surgeon must insert different size implants. Type III DPBA allegedly raises the NAC, although this remains controversial. Advocates purport lifting based on before-and-after photographs without providing objective proof, [34] [35] [36] while other authors demonstrate postoperative SN-N lengthening 37 or disagree with the logic that prepectoral dissection allows the NAC to pivot upward. 38, 39 A benefit of DPBA is that scars are concealed within the IMF, similar to LAM. LAM's primary weakness compared to its MAM and RAM counterparts is less predictability. So many variables affect the degree of lift (eg, breast mass, skin elasticity, scar strength, postoperative compliance) and delta SN-Ns range so widely that it is difficult to forecast how much liposuction to perform or whether more suctioning will increase lift. Given that nipple height did not vary proportionally with suction volume on a per patient basis, and that breasts with low aspirate volumes (<100 cc) did not vary significantly from those with higher aspirate volumes (>200 cc), we speculate that each breast has an upper limit of SN-N improvement. Nevertheless, the data do show that: (1) (2) in patients undergoing unilateral LAM and contralateral augmentation mirroring Type I DPBA, 34 the latter achieves virtually no lift, while the LAM side attains significant lifting -even when accounting for patients who were neither pursuing nor achieved any lifting (see below). At this point, the 14 LAM patients with poor outcomes (based on worsened or unchanged SN-N length), and the seemingly meager 6% average lifting bear mentioning. The worst result had unanticipated egregious skin tone ( Figure 6 ). Despite her young age and paucity of stretch marks, her areolae enlarged significantly after surgery, and her SN-N distances actually lengthened. One subset of patients (n = 4) already had prior primary augmentation mammaplasty but desired even larger, scarlessly lifted breasts. We speculate that the initial procedure compromised their skin elasticity, thwarting the success that a primary LAM would have otherwise achieved. In another subset of patients who underwent unilateral LAM, some did so solely for volumetric equalization (n = 6), others had grade 0 ptosis requiring no elevation (n = 4), while the remaining began with a higher NAC on the operated breast (n = 4). Of course, it is likely that some patients did not faithfully adhere to pre-and postoperative instructions, while others may have formed inadequate internal scars. Subtracting these 14 patients from our analysis improves the mean delta SN-N to 8%.
Importantly, the majority of our numerical failures can be ascribed to methodology failure. In this study, delta A total of 25 cc of fat was removed from the right breast, and 300 cc implants were placed bilaterally. This patient illustrates the worst outcome in our series-she was noted to have persistent breast ptosis and areolae that enlarged by nearly 50%, although she did gain 12 pounds and gave birth in the interim. She is considering converting to MAM in the near future.
SN-N was the sole barometer of success. While easily measured and requiring only anteroposterior views, this metric does not capture the whole story. In many cases, we only suctioned small amounts to even out volumetric asymmetries prior to inserting same size implants or to improve centralization of the implant under the breast mound ( Figure 1) . Thus, it is unfair to compare the efficacy of LAM to MAM and RAM based on SN-N improvement alone when the primary aim of the latter two procedures is to effect more radical lifting. On review of the results, 10 of the 14 abovementioned patients actually experienced improved cosmesis (per patient satisfaction and surgeon judgment). The SN-N metric has several limitations: it is based on two-dimensional photographs; it relies heavily on camera angle/torso rotation; and the sternal notch and axillae can be difficult to discern on obese patients or those with a prominent tail of Spence. Moreover, normalizing SN-N distances by interaxillary length can be complicated by posture (eg, pulled back or hunched shoulders), respiratory phase, larger or high-riding implant (pushes axillary fold laterally), or liposuction to the anterior axillary fat pad (displaces axillary fold medially).
We opted against Regnault's classification of breast ptosis, which has been called into question. 40, 41 Not only is it a physical exam measurement 1 that does not lend itself to a retrospective study like ours, but it also lacks sufficient gradation along the "normal" spectrum. Thus, it fails to identify many lifting candidates whose nipples lie above the IMF (Figure 7 ) and precludes any assessment of post-LAM improvement. Subareola skin show was considered an unreliable gauge and was forgone in this study due to NAC manipulation inherent in MAMs and RAMs and expansion of the subareola skin caused by implantation. 39 Studies analyzing other metrics (eg, IMF-inferior areola arc length, breast parenchymal ratio, 41 ground-to-nipple distance, breast footprint position, or actual SN-N distances on live patients) could add further insight.
Our large-scale breast series was made possible by combining the patients of two surgeons. Any skepticism regarding idiosyncrasies between them can be allayed by the fact that both employ the same technique and have comparable outcomes. Our mean follow up is consistent with the literature, but given that our postoperative measurements were made on a single photograph at various junctures, a longitudinal study could better evaluate LAM's efficacy over a longer time period. Patient satisfaction surveys and independent surgeon ratings could prove valuable as well.
This paper contributes to the knowledge base in several ways: (1) it introduces a new procedure to the cosmetic surgeon's armamentarium; (2) it details the operative technique and postoperative instructions that are crucial for optimal results; (3) it reviews proper patient selection; (4) it promotes the relevant concept of breast volumetrics; (5) it raises awareness of liposuction in the breast as a "scarless" lift technique and theorizes how this occurs; (6) it demonstrates the efficacy of LAM by comparing it two contemporaneous procedures with similar aims; and (7) it proves that liposuction performed concomitantly with augmentation is safe in the breast.
CONCLUSIONS
Given the prevalence of breast asymmetry among women and their reluctance to visible, anterior scars, LAM offers a fast, safe, and facile approach to achieving lifted, firmer, fuller (especially superiorly) breasts. It combines the lifting of DPBA and the volume reduction of DPR to promote symmetric implant insertion. It is extremely versatile with regard to breast volumetrics, catering to those who wish to go bigger, smaller, or stay the same size. Patients with minor preoperative asymmetries benefit greatly, whereas those with severe ptosis or poor elasticity are better candidates for MAM or RAM. One can expect roughly half the lift of a MAM given sufficient fat to suction and strict postoperative compliance. The result is a leaner, more prosthetic breast that is less pervious to the ravages of time, gravity, and weight changes. Table 3 Supplementary Material This article contains supplementary material located online at www.aestheticsurgeryjournal.com.
